VIVS
VivoSim Labs, Inc.
NASDAQ: VIVS · HEALTHCARE · BIOTECHNOLOGY
$1.44
-3.36% today
Updated 2026-04-29
Market cap
$4.34M
P/E ratio
0.85
P/S ratio
30.58x
EPS (TTM)
$1.76
Dividend yield
—
52W range
$1 – $5
Volume
0.1M
VivoSim Labs, Inc. (VIVS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $1.20M | $379000.00 | $571000.00 | $1.48M | $4.23M | $4.60M | $3.09M | $2.20M | $0.00 | $1.50M | $370000.00 | $109000.00 | $144000.00 |
| Revenue growth (YoY) | — | — | -68.3% | +50.7% | +159.7% | +185.2% | +8.8% | -32.8% | -29.0% | -100.0% | — | -75.3% | -70.5% | +32.1% |
| Cost of revenue | — | — | — | — | — | $956000.00 | $1.03M | $482000.00 | $328000.00 | $0.00 | — | — | $0.00 | $5000.00 |
| Gross profit | — | $1.20M | $379000.00 | $571000.00 | $1.48M | $3.27M | $3.57M | $2.61M | $1.87M | $0.00 | $1.50M | $370000.00 | $109000.00 | $139000.00 |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 77.4% | 77.6% | 84.4% | 85.1% | — | 100.0% | 100.0% | 100.0% | 96.5% |
| R&D | — | $3.44M | $7.97M | $12.92M | $18.01M | $19.55M | $17.96M | $14.75M | $5.28M | $1.10M | $3.32M | $8.88M | $5.50M | $5.03M |
| SG&A | — | — | — | — | — | — | — | $14.70M | $17.15M | $15.71M | $9.63M | $9.09M | $9.64M | $7.69M |
| Operating income | — | $-9.32M | $-20.65M | $-30.30M | $-38.64M | $-38.58M | $-35.27M | $-27.27M | $-21.48M | $-16.83M | $-11.48M | $-17.73M | $-15.09M | $-12.62M |
| Operating margin | — | -778.5% | -5448.3% | -5306.0% | -2605.7% | -911.9% | -766.3% | -882.4% | -977.9% | — | -765.3% | -4792.2% | -13840.4% | -8761.1% |
| EBITDA | $-117817.00 | $-42.27M | $-25.45M | $-29.61M | $-37.83M | $-37.43M | $-34.00M | $-26.29M | $-20.33M | $-16.79M | $-11.34M | $-17.44M | $-14.81M | $-2.21M |
| EBITDA margin | — | -3531.3% | -6714.5% | -5185.5% | -2550.8% | -884.8% | -738.7% | -850.7% | -925.9% | — | -755.8% | -4713.0% | -13583.5% | -1534.7% |
| EBIT | $-120094.00 | $-42.47M | $-25.84M | $-30.08M | $-38.64M | $-38.58M | $-35.27M | $-27.27M | $-21.48M | $-16.83M | $-11.48M | $-17.73M | $-15.09M | $-2.48M |
| Interest expense | — | $1.09M | $13000.00 | $1000.00 | — | — | — | — | — | — | — | — | $0.00 | $10000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-147817.00 | $-43.55M | $-25.85M | $-30.08M | $-38.58M | $-38.45M | $-34.80M | $-26.64M | $-18.71M | $-16.83M | $-11.45M | $-17.26M | $-14.67M | $-2.49M |
| Net income growth (YoY) | — | -29364.1% | +40.7% | -16.4% | -28.2% | +0.3% | +9.5% | +23.5% | +29.8% | +10.1% | +32.0% | -50.8% | +15.0% | +83.0% |
| Profit margin | — | -3638.5% | -6820.1% | -5268.3% | -2601.1% | -908.9% | -756.1% | -861.7% | -852.0% | — | -763.2% | -4664.6% | -13459.6% | -1727.8% |